Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies to reduce use of antidepressants
Tony Kendrick
British Journal of Clinical Pharmacology (2020) Vol. 87, Iss. 1, pp. 23-33
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Primary care healthcare professionals supporting patients to discontinue antidepressants: A scoping review of barriers, enablers and interventions
Bethany Atkins, Michelle Maden, Linda Birt, et al.
Research in Social and Administrative Pharmacy (2025)
Closed Access | Times Cited: 1
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?
Edward White, John Read, Sherry Julo
Therapeutic Advances in Psychopharmacology (2021) Vol. 11, pp. 204512532098117-204512532098117
Open Access | Times Cited: 54
Antidepressant prescribing for adult people with an intellectual disability living in England
David Branford, Rohit Shankar
The British Journal of Psychiatry (2022) Vol. 221, Iss. 2, pp. 488-493
Closed Access | Times Cited: 26
Designing withdrawal support services for antidepressant users: Patients’ views on existing services and what they really need
John Read, Joanna Moncrieff, Mark Horowitz
Journal of Psychiatric Research (2023) Vol. 161, pp. 298-306
Open Access | Times Cited: 16
Minocycline alleviates abnormal microglial phagocytosis of synapses in a mouse model of depression
Qiu-Qin Han, Shi-Yu Shen, Xiaorong Chen, et al.
Neuropharmacology (2022) Vol. 220, pp. 109249-109249
Closed Access | Times Cited: 18
The need for antidepressant withdrawal support services: Recommendations from 708 patients
John Read, Stevie Lewis, Mark Horowitz, et al.
Psychiatry Research (2023) Vol. 326, pp. 115303-115303
Open Access | Times Cited: 10
Screening for depression and anxiety in general practice
Brett D. Thombs, Sarah Markham, Danielle B. Rice, et al.
BMJ (2023), pp. p1615-p1615
Closed Access | Times Cited: 10
The Feasibility of Delivering Two Brief Psychotherapies for the Treatment of Depression in Primary Care
Marie Crowe, Jennifer Jordan, Richard Porter, et al.
Counselling and Psychotherapy Research (2025) Vol. 25, Iss. 1
Open Access
Predicting intentions towards long-term antidepressant use in the management of people with depression in primary care: A longitudinal survey study
Rachel Dewar-Haggart, Ingrid Müller, Felicity L. Bishop, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0299676-e0299676
Open Access
Does volunteering reduce antidepressant use among older adults? Longitudinal register-based evidence from Denmark
Hans‐Peter Y. Qvist, Jeevitha Yogachandiran Qvist, Dingeman Wiertz
Social Science Research (2025) Vol. 128, pp. 103172-103172
Open Access
Pharmacoepidemiology of antidepressants in the Russian Federation
Yu. М. Gomon, А. С. Колбин, V. A. Lavrova, et al.
Real-World Data & Evidence (2025) Vol. 5, Iss. 1, pp. 49-58
Open Access
A systematic review of manipulations to pharmaceutical dosage forms used in psychotropic tapering plans
Denis O’Brien, Anne Marie Healy, Andrew Harkin, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Integration of Non-Targeted Metabolomics and Targeted Quantitative Analysis to Elucidate the Synergistic Antidepressant Effect of Bupleurum Chinense DC-Paeonia Lactiflora Pall Herb Pair by Regulating Purine Metabolism
Jiajun Chen, Li Tian, Xuemei Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Exosomes may be the carrier of acupuncture treatment for major depressive disorder
Qin Lyu, Xin Zhou, Liuqing Shi, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population
Melanie Alexandra Amrein, Michael P. Hengartner, Markus Näpflin, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 11, pp. 1505-1513
Open Access | Times Cited: 7
Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long-term use
Aoibhin McCool, Kurt Lukas, Peter Hayes, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 5, pp. 2239-2246
Open Access | Times Cited: 16
Psychedelic Therapy: A Primer for Primary Care Clinicians—The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
Owen S. Muir, Kenneth Shinozuka, Bryce D. Beutler, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e178-e182
Closed Access | Times Cited: 2
Sleep bruxism (SB) may be not associated with obstructive sleep apnea (OSA): a comprehensive assessment employing a systematic review and meta-analysis
Bartłomiej Błaszczyk, Marta Waliszewska‐Prosół, Mieszko Więckiewicz, et al.
Sleep Medicine Reviews (2024) Vol. 78, pp. 101994-101994
Open Access | Times Cited: 2
Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards
Vita Brisnik, Marietta Rottenkolber, Jochen Vukas, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Stimulation of astrocytic sigma-1 receptor is sufficient to ameliorate inflammation- induced depression
Lin Guo, Tianyu Gao, Ce Gao, et al.
Behavioural Brain Research (2021) Vol. 410, pp. 113344-113344
Closed Access | Times Cited: 15
Foodborne fluoxetine impacts the immune response in rainbow trout (Oncorhynchus mykkis)
Josef Václavík, Pavla Sehonová, Jana Blahová, et al.
Environmental Toxicology and Pharmacology (2022) Vol. 90, pp. 103818-103818
Closed Access | Times Cited: 11
Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric Drugs
Eunkyung Jo, Myeonghan Ryu, Georgia Kenderova, et al.
CHI Conference on Human Factors in Computing Systems (2022), pp. 1-17
Open Access | Times Cited: 10
Understanding Delivery of Collectively Built Protocols in an Online Health Community for Discontinuation of Psychiatric Drugs
Alexandra Papoutsaki, Samuel So, Georgia Kenderova, et al.
Proceedings of the ACM on Human-Computer Interaction (2021) Vol. 5, Iss. CSCW2, pp. 1-29
Open Access | Times Cited: 14
Absetzen von Antidepressiva – Absetzsymptome und Rebound-Effekte
Tom Bschor, Udo Bonnet, Martina Pitzer, et al.
Der Nervenarzt (2022) Vol. 93, Iss. 1, pp. 93-101
Closed Access | Times Cited: 9
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist
Amy McGoldrick, Helen M. Byrne, Cathal Cadogan
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 5, pp. 1074-1087
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top